PF
Patrick John Finn
President and COO

Patrick John Finn insider trades: Twist Bioscience (TWST) stock sales

President and COO, Twist Bioscience Last trade Nov 3, 2026 139 Form 4 filings
$21.2M
Sold, last 12 months
15 sales
$0
Bought, last 12 months
0 buys
75
Open-market trades
since 2019
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Patrick reports to the SEC

Open-market buys and sales

75 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 3, 2026TWST↓ Sell$347K
Oct 23, 2026TWST↓ Sell$302K
Oct 2, 2026TWST↓ Sell$4.9M
Aug 21, 2026TWST↓ Sell$563K
Aug 18, 2026TWST↓ Sell$9.2M
Aug 3, 2026TWST↓ Sell$246K
May 21, 2026TWST↓ Sell$222K
May 4, 2026TWST↓ Sell$163K
Feb 23, 2026TWST↓ Sell$201K
Feb 17, 2026TWST↓ Sell$3.6M
Feb 13, 2026TWST↓ Sell$263K
Feb 3, 2026TWST↓ Sell$126K
Jan 23, 2026TWST↓ Sell$107K
Jan 13, 2026TWST↓ Sell10b5-1$931K
Nov 21, 2025TWST↓ Sell$47K
Nov 3, 2025TWST↓ Sell$88K
Oct 30, 2025TWST↓ Sell$554K
Oct 23, 2025TWST↓ Sell$69K
Oct 6, 2025TWST↓ Sell$764K
Oct 2, 2025TWST↓ Sell$6K
Aug 21, 2025TWST↓ Sell$48K
Aug 4, 2025TWST↓ Sell$90K
Jul 23, 2025TWST↓ Sell$80K
Jul 2, 2025TWST↓ Sell$8K
May 21, 2025TWST↓ Sell$56K
May 8, 2025TWST↓ Sell$646K
May 5, 2025TWST↓ Sell$105K
Apr 23, 2025TWST↓ Sell$82K
Apr 2, 2025TWST↓ Sell$8K
Feb 21, 2025TWST↓ Sell$81K
Feb 3, 2025TWST↓ Sell$140K
Jan 23, 2025TWST↓ Sell$122K
Jan 3, 2025TWST↓ Sell$10K
Nov 11, 2024TWST↓ Sell$496K
Nov 6, 2024TWST↓ Sell$278K
Nov 4, 2024TWST↓ Sell$111K
Oct 23, 2024TWST↓ Sell$97K
Oct 2, 2024TWST↓ Sell$297K
Aug 5, 2024TWST↓ Sell$115K
Jul 23, 2024TWST↓ Sell$125K
Jul 2, 2024TWST↓ Sell$23K
May 3, 2024TWST↓ Sell$86K
Apr 23, 2024TWST↓ Sell$65K
Apr 2, 2024TWST↓ Sell$16K
Feb 1, 2022TWST↓ Sell$40K
Dec 29, 2021TWST↓ Sell$453K
Dec 22, 2021TWST↓ Sell$510K
Dec 21, 2021TWST↓ Sell$18K
Dec 2, 2021TWST↓ Sell$155K
Nov 2, 2021TWST↓ Sell$224K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TWST insiders

Open-market trades in the last 12 months

About Patrick John Finn's insider trades

Patrick John Finn is President and COO at Twist Bioscience (TWST). Since Sep 26, 2019, Patrick has reported no open-market purchases and 75 sales worth $39.3M on SEC Form 4. In the last 12 months: 15 sales ($21.2M).

1 sale (2% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include shares withheld for taxes (50 filings), option exercises (34 filings), grants and awards (12 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TWST insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.